Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers In Non ST Elevated acUte Coronary Syndromes With Initial Invasive Indication

NCT02618837 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT02618837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02618837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers In Non ST Elevated acUte Coronary Syndromes With Initial Invasive Indication
Lead sponsor
University of Padova
Phase
Phase 4
Overall status
Unknown status
Start date
December 14, 2015
Completion date
August 31, 2022
Enrollment
2,520 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unstable angina or non st elevated myocardial infarction